Rivastigmine
Common brands: Exelon, Rivastigmine Transdermal System, Nuplazid, Seroquel Xr, Seroquel
Top reporter: Sandoz Inc
Cholinesterase Inhibitor [EPC]Atypical Antipsychotic [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Aromatic Amino Acid [EPC]Benzodiazepine [EPC]
18,392
Total Reports
8,481
Serious Reports
4,674
Death Reports
30
Reported Reactions
Death Report Ratio: High (25.41%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Rivastigmine.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | DEATH | 2,265 | |
| 2 | FALL | 1,701 | |
| 3 | HALLUCINATION | 1,400 | |
| 4 | CONFUSIONAL STATE | 1,275 | |
| 5 | DRUG INEFFECTIVE | 917 | |
| 6 | VOMITING | 897 | |
| 7 | NAUSEA | 838 | |
| 8 | DIZZINESS | 793 | |
| 9 | GAIT DISTURBANCE | 720 | |
| 10 | PNEUMONIA | 704 | |
| 11 | MALAISE | 660 | |
| 12 | SOMNOLENCE | 658 | |
| 13 | DIARRHOEA | 648 | |
| 14 | FATIGUE | 646 | |
| 15 | URINARY TRACT INFECTION | 624 | |
| 16 | ASTHENIA | 618 | |
| 17 | CONDITION AGGRAVATED | 601 | |
| 18 | TREMOR | 582 | |
| 19 | WEIGHT DECREASED | 582 | |
| 20 | PARKINSON^S DISEASE | 577 | |
| 21 | MEMORY IMPAIRMENT | 569 | |
| 22 | DEMENTIA | 561 | |
| 23 | GENERAL PHYSICAL HEALTH DETERIORATION | 557 | |
| 24 | OFF LABEL USE | 550 | |
| 25 | AGITATION | 534 | |
| 26 | AGGRESSION | 516 | |
| 27 | DECREASED APPETITE | 498 | |
| 28 | INSOMNIA | 452 | |
| 29 | CEREBROVASCULAR ACCIDENT | 449 | |
| 30 | DYSPHAGIA | 435 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.